142 related articles for article (PubMed ID: 11310216)
1. Effects of citrate on renal stone formation and osteopontin expression in a rat urolithiasis model.
Yasui T; Sato M; Fujita K; Tozawa K; Nomura S; Kohri K
Urol Res; 2001 Feb; 29(1):50-6. PubMed ID: 11310216
[TBL] [Abstract][Full Text] [Related]
2. Effects of allopurinol on renal stone formation and osteopontin expression in a rat urolithiasis model.
Yasui T; Sato M; Fujita K; Ito Y; Nomura S; Kohri K
Nephron; 2001 Feb; 87(2):170-6. PubMed ID: 11244313
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of female sex hormones on urinary stone formation in rats.
Iguchi M; Takamura C; Umekawa T; Kurita T; Kohri K
Kidney Int; 1999 Aug; 56(2):479-85. PubMed ID: 10432386
[TBL] [Abstract][Full Text] [Related]
4. The effect of takusha, a kampo medicine, on renal stone formation and osteopontin expression in a rat urolithiasis model.
Yasui T; Fujita K; Sato M; Sugimoto M; Iguchi M; Nomura S; Kohri K
Urol Res; 1999 Jun; 27(3):194-9. PubMed ID: 10422821
[TBL] [Abstract][Full Text] [Related]
5. Expression of bone matrix proteins in urolithiasis model rats.
Yasui T; Fujita K; Sasaki S; Sato M; Sugimoto M; Hirota S; Kitamura Y; Nomura S; Kohri K
Urol Res; 1999 Aug; 27(4):255-61. PubMed ID: 10460895
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin mRNA in the kidney on an experimental rat model of renal stone formation without renal failure.
Umekawa T; Yamate T; Amasaki N; Kohri K; Kurita T
Urol Int; 1995; 55(1):6-10. PubMed ID: 7571189
[TBL] [Abstract][Full Text] [Related]
7. Astaxanthin modulates osteopontin and transforming growth factor β1 expression levels in a rat model of nephrolithiasis: a comparison with citrate administration.
Alex M; Sauganth Paul MV; Abhilash M; Mathews VV; Anilkumar TV; Nair RH
BJU Int; 2014 Sep; 114(3):458-66. PubMed ID: 24712822
[TBL] [Abstract][Full Text] [Related]
8. The influence of sex hormones on renal osteopontin expression and urinary constituents in experimental urolithiasis.
Yagisawa T; Ito F; Osaka Y; Amano H; Kobayashi C; Toma H
J Urol; 2001 Sep; 166(3):1078-82. PubMed ID: 11490302
[TBL] [Abstract][Full Text] [Related]
9. Regulation of osteopontin expression in a rat model of urolithiasis.
Chang L; Feng T; Li J; Dou C; Wei J; Guo Y
Chin Med J (Engl); 2001 Aug; 114(8):829-32. PubMed ID: 11780360
[TBL] [Abstract][Full Text] [Related]
10. Expression of osteopontin messenger RNA in the rat kidney on experimental model of renal stone.
Umekawa T; Kohri K; Kurita T; Hirota S; Nomura S; Kitamura Y
Biochem Mol Biol Int; 1995 Jan; 35(1):223-30. PubMed ID: 7735136
[TBL] [Abstract][Full Text] [Related]
11. Expression of osteopontin mRNA in normal and stone-forming rat kidney.
Jiang XJ; Feng T; Chang LS; Kong XT; Wang G; Zhang ZW; Guo YL
Urol Res; 1998; 26(6):389-94. PubMed ID: 9879818
[TBL] [Abstract][Full Text] [Related]
12. Alendronate inhibits osteopontin expression enhanced by parathyroid hormone-related peptide (PTHrP) in the rat kidney.
Yasui T; Fujita K; Sasaki S; Iguchi M; Hirota S; Nomura S; Azuma Y; Ohta T; Kohri K
Urol Res; 1998; 26(5):355-60. PubMed ID: 9840346
[TBL] [Abstract][Full Text] [Related]
13. Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of renal calculi.
McKee MD; Nanci A; Khan SR
J Bone Miner Res; 1995 Dec; 10(12):1913-29. PubMed ID: 8619372
[TBL] [Abstract][Full Text] [Related]
14. Expression of osteopontin in rat kidneys: induction during ethylene glycol induced calcium oxalate nephrolithiasis.
Khan SR; Johnson JM; Peck AB; Cornelius JG; Glenton PA
J Urol; 2002 Sep; 168(3):1173-81. PubMed ID: 12187263
[TBL] [Abstract][Full Text] [Related]
15. Renal osteopontin expression in experimental urolithiasis.
Yagisawa T; Chandhoke PS; Fan J; Lucia S
J Endourol; 1998 Apr; 12(2):171-6. PubMed ID: 9607445
[TBL] [Abstract][Full Text] [Related]
16. Preventive effects of green tea on renal stone formation and the role of oxidative stress in nephrolithiasis.
Itoh Y; Yasui T; Okada A; Tozawa K; Hayashi Y; Kohri K
J Urol; 2005 Jan; 173(1):271-5. PubMed ID: 15592095
[TBL] [Abstract][Full Text] [Related]
17. Structure and expression of the mRNA encoding urinary stone protein (osteopontin).
Kohri K; Nomura S; Kitamura Y; Nagata T; Yoshioka K; Iguchi M; Yamate T; Umekawa T; Suzuki Y; Sinohara H
J Biol Chem; 1993 Jul; 268(20):15180-4. PubMed ID: 8325891
[TBL] [Abstract][Full Text] [Related]
18. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
Schwille PO; Schmiedl A; Manoharan M
Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
[TBL] [Abstract][Full Text] [Related]
19. Decreased renal expression of the putative calcium oxalate inhibitor Tamm-Horsfall protein in the ethylene glycol rat model of calcium oxalate urolithiasis.
Marengo SR; Chen DH; Kaung HL; Resnick MI; Yang L
J Urol; 2002 May; 167(5):2192-7. PubMed ID: 11956477
[TBL] [Abstract][Full Text] [Related]
20. Sodium dicarboxylate cotransporter-1 expression in renal tissues and its role in rat experimental nephrolithiasis.
He Y; Chen X; Yu Z; Wu D; Lv Y; Shi S; Zhu H
J Nephrol; 2004; 17(1):34-42. PubMed ID: 15151257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
